GGrantIndex
Sort

25,944 grants matching neurodegeneration

NanoLuciferase-based AD/ADRD Microphysiological Systems Platform for High-throughput Screening

$500,000
Wayne W Poon · Neucyte, Inc. · R41 · FY2024 · AG

Miniaturized AD/ADRD Microphysiological Systems Platform for High-throughput Screening

$500,000
Wayne W Poon · Neucyte, Inc. · R41 · FY2023 · AG

Epigenetic Analysis of iPS Cell Models of Aging and Alzheimer's Disease

$500,000
Bruce A Yankner · Harvard Medical School · RC1 · FY2009 · AG

Serological profiling of the human virome and ALS risk in a military population

$500,000
Alberto Ascherio · Harvard School Of Public Health · R01 · FY2020 · TS

Exosome based therapeutics in Huntington's disease

$500,000
Neil Aronin · Univ Of Massachusetts Med Sch Worcester · UH2 · FY2013 · TR

Diet and Exercise (DE) Program for Alzheimer Prevention

$500,000
Gregory M Cole · University Of California Los Angeles · RC1 · FY2010 · AG

Treatment of Alzheimer's disease by clearing both tau and amyloid beta pathologies

$500,000
Khalid Iqbal · Phanes Biotech, Inc. · R43 · FY2022 · AG

RES FACIL CONST: AGING, ALZHEIMER

$500,000
University Of California Santa Barbara · C06 · FY2002 · RR

RES FACIL CONST: PARKINSON

$500,000
University Of California Santa Barbara · C06 · FY2002 · RR

RES FACIL CONST: MACULAR DEGENERATION

$500,000
University Of California Santa Barbara · C06 · FY2002 · RR

RES FACIL CONST: CANCER, TAXOL

$500,000
University Of California Santa Barbara · C06 · FY2002 · RR

CAREER: Self-Clearing Glutamate Biosensor Towards Chronic Neurodegeneration Monitoring

$500,000
Hyowon Lee · Purdue University · · FY2020 · ENG

Multi-target Peptide Drug for Alzheimer's Disease

$500,000
Anne Kasus-Jacobi · Alzarrok Bio Llc · R41 · FY2024 · AG

Transmission Electron Microscope for Core EM Facility

$500,000
Roger W Craig · Univ Of Massachusetts Med Sch Worcester · S10 · FY2009 · RR

Metabolomic Signatures Linking ALS to Persistent Organic Pollutant Exposures

$500,000
Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2019 · TS

Metabolomic Signatures Linking ALS to Persistent Organic Pollutant Exposures

$500,000
Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2018 · TS

Mechanisms of Ethanol-Induced Neuroinflammation and Neurodegeneration

$499,999
Paul D Drew · Univ Of Arkansas For Med Scis · RC1 · FY2010 · AA

Mechanisms of Ethanol-Induced Neuroinflammation and Neurodegeneration

$499,999
Paul D Drew · Univ Of Arkansas For Med Scis · RC1 · FY2009 · AA

System for advanced automated 3D microvascular analysis in neuroplasticity

$499,991
Paul Angstman · Microbrightfield, Llc · R44 · FY2018 · MH

Mitochondrial Protection in Glaucomatous Optic Neuropathy

$499,975
Wonkyu Ju · University Of California, San Diego · R01 · FY2023 · EY

Optimization of Novel Potassium Channel Kv1.3 Blockers with Potential as Alzheimer's Disease Therapeutics

$499,968
John A Butera · Hager Biosciences, Llc · R43 · FY2024 · AG

Elucidating mechanisms of SIRT1 activation

$499,967
David A. Sinclair · Harvard Medical School · R01 · FY2019 · DK

CNS Gene Therapy for CLN2 Disease Using Parallel Multiple Routes of Administration

$499,916
Ronald G Crystal · Lexeo Therapeutics, Llc · R41 · FY2020 · NS

CAREER: An artificial nervous system for in-body communication between wearable and implantable devices

$499,896
Alex Abramson · Georgia Tech Research Corporation · · FY2025 · ENG

System for advanced automated 3D microvascular analysis in neuroplasticity

$499,871
Paul Angstman · Microbrightfield, Llc · R44 · FY2017 · MH